Literature DB >> 23815093

Dopaminergic medication counteracts conflict adaptation in patients with Parkinson's disease.

Wout Duthoo1, Senne Braem, Femke Houtman, Nathalie Schouppe, Patrick Santens, Wim Notebaert.   

Abstract

OBJECTIVE: We tested the role of dopamine in conflict-induced behavioral adjustments by evaluating the effect of dopaminergic medication on conflict adaptation in Parkinson's disease (PD) patients.
METHOD: Nine PD patients performed a vocal Stroop task on two separate testing occasions: once on their regular medication and once after overnight withdrawal.
RESULTS: In line with previous studies (e.g., Bonnin, Houeto, Gil, & Bouquet, 2010), patients displayed no conflict adaptation when tested on medication. However, the same patients tested off of their medication did display a conflict adaptation effect in that the size of the interference effect was reduced after incongruent trials compared with after congruent trials.
CONCLUSIONS: This difference is discussed in terms of an inverted U-shaped relation between dopamine and performance, according to which dopaminergic medication has detrimental effects on PD patients' performance by overdosing brain regions that are relatively spared in the initial stage of the disease, including the ventral striatum and prefrontal cortex.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23815093     DOI: 10.1037/a0033377

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  7 in total

1.  Dopamine Selectively Modulates the Outcome of Learning Unnatural Action-Valence Associations.

Authors:  Nelleke C Van Wouwe; Daniel O Claassen; Joseph S Neimat; Kristen E Kanoff; Scott A Wylie
Journal:  J Cogn Neurosci       Date:  2017-01-27       Impact factor: 3.225

2.  Dopa therapy and action impulsivity: subthreshold error activation and suppression in Parkinson's disease.

Authors:  Frédérique Fluchère; Manon Deveaux; Borís Burle; Franck Vidal; Wery P M van den Wildenberg; Tatiana Witjas; Alexandre Eusebio; Jean-Philippe Azulay; Thierry Hasbroucq
Journal:  Psychopharmacology (Berl)       Date:  2014-12-16       Impact factor: 4.530

3.  The congruency sequence effect 3.0: a critical test of conflict adaptation.

Authors:  Wout Duthoo; Elger L Abrahamse; Senne Braem; C Nico Boehler; Wim Notebaert
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

4.  Dopaminergic modulation of performance monitoring in Parkinson's disease: An event-related potential study.

Authors:  Caroline Seer; Florian Lange; Sebastian Loens; Florian Wegner; Christoph Schrader; Dirk Dressler; Reinhard Dengler; Bruno Kopp
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

5.  Action Observation Plus Sonification. A Novel Therapeutic Protocol for Parkinson's Patient with Freezing of Gait.

Authors:  Susanna Mezzarobba; Michele Grassi; Lorella Pellegrini; Mauro Catalan; Bjorn Kruger; Giovanni Furlanis; Paolo Manganotti; Paolo Bernardis
Journal:  Front Neurol       Date:  2018-01-04       Impact factor: 4.003

6.  Conflict adaptation and related neuronal processing in Parkinson's disease.

Authors:  Rea Rodriguez-Raecke; Christoph Schrader; Pawel Tacik; Dirk Dressler; Heinrich Lanfermann; Matthias Wittfoth
Journal:  Brain Imaging Behav       Date:  2021-08-27       Impact factor: 3.978

7.  Distributional analyses reveal the individual differences in congruency sequence effect.

Authors:  Dandan Tang; Xuefei Chen; Hong Li; Yi Lei
Journal:  PLoS One       Date:  2022-08-22       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.